TherapeuticsMD (TXMD) Change in Inventory (2011 - 2022)
TherapeuticsMD's (TXMD) quarterly Change in Inventory came in at $551000.0 in Q3 2022, up 49.73% on a YoY basis from $368000.0 in Q3 2021, and up 119.56% quarter-over-quarter from -$2.8 million in Q2 2022.
Analysis
TherapeuticsMD (TXMD) Change in Inventory (2011 - 2022) Analysis & Trends
TherapeuticsMD (TXMD) has reported Change in Inventory for 12 consecutive years, with $551000.0 the latest figure, recorded in Q3 2022.
- For the quarter ending Q3 2022, Change in Inventory rose 49.73% year-over-year to $551000.0; the trailing twelve-month figure through Sep 2022 stood at -$588000.0 (down 2000.0% YoY), and the FY2021 full-year result was $711000.0, down 78.69% from the prior year.
- Change in Inventory rose to $551000.0 in Q3 2022 per TXMD's latest filing, from -$2.8 million in the prior quarter.
- Across five years, Change in Inventory topped out at $3.0 million in Q3 2019 and bottomed at -$2.8 million in Q2 2022.
- Historically, Change in Inventory has averaged $714490.1 across 5 years, with a median of $497644.0 in 2018.
- The sharpest annual moves came in 2019 and 2022: Change in Inventory soared 1145.66% in 2019, then slumped 1335.53% in 2022.
- Over 5 years, Change in Inventory stood at $889449.0 in 2018, then soared by 49.29% to $1.3 million in 2019, then sank by 136.07% to -$479000.0 in 2020, then surged by 154.28% to $260000.0 in 2021, then jumped by 111.92% to $551000.0 in 2022.
- According to Business Quant data, Change in Inventory over the past three periods registered $551000.0, -$2.8 million, and $1.4 million for Q3 2022, Q2 2022, and Q1 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 571.00 Mn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 143.00 Mn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 36.00 Mn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | - |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 47.15 Mn |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | 551,000.00 |
| Jun 30, 2022 | -2.82 Mn |
| Mar 31, 2022 | 1.42 Mn |
| Dec 31, 2021 | 260,000.00 |
| Sep 30, 2021 | 368,000.00 |
| Jun 30, 2021 | 228,000.00 |
| Mar 31, 2021 | -145,000.00 |
| Dec 31, 2020 | -479,000.00 |
| Sep 30, 2020 | -461,000.00 |
| Jun 30, 2020 | 1.39 Mn |
| Mar 31, 2020 | 2.88 Mn |
| Dec 31, 2019 | 1.33 Mn |
| Sep 30, 2019 | 3.04 Mn |
| Jun 30, 2019 | 2.54 Mn |
| Mar 31, 2019 | 1.69 Mn |
| Dec 31, 2018 | 889,449.00 |
| Sep 30, 2018 | 497,644.00 |
| Jun 30, 2018 | 259,705.00 |
| Mar 31, 2018 | 135,514.00 |
| Dec 31, 2017 | 191,841.00 |